Acer Medical, which specializes in Medical AI diagnostics solutions to increase diagnostic efficiency and solve the problem of insufficient healthcare resources, has been listed on the Taiwan emerging stock market. The company’s AI solution, VeriSee DR, has been approved by Taiwan FDA, Thailand FDA, Indonesia MoH, and the Philippines FDA. It has now been officially launched in five Southeast Asia countries including Thailand, Indonesia, Philippines, Vietnam, and India to further enhance the care quality of diabetic patients. Besides being implemented in half of the medical centers in Taiwan, VeriSee DR has also been introduced and implemented in hospitals in Thailand and India.
